Geneos Wealth Management Inc. Novo Cure LTD Transaction History

Geneos Wealth Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$40.29 - $82.51 $1,611 - $3,300	40 New	40 $1,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $3,059 - $4,030	-45 Reduced 33.33%	90 $6,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $601 - $845	-10 Reduced 6.9%	135 $11,000
Q4 2021 Feb 09, 2022	BUY	$75.08 - $121.99 $10,886 - $17,688	145 New	145 $10,000
Q1 2019 Sep 07, 2021	SELL	$31.96 - $56.12 $6,392 - $11,224	-200 Closed	0 $0
Q4 2018 Sep 07, 2021	BUY	$28.72 - $52.63 $5,744 - $10,526	200 New	200 $6,000
Q2 2016 Sep 07, 2021	SELL	N/A	-100 Closed	0 $0
Q1 2016 Sep 07, 2021	BUY	N/A	100	100 $1,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.